Reduced breast cancer incidence in women treated with subcutaneous testosterone, or tes... - 0 views
-
Nathan Goodyear on 20 Mar 14Study finds that Testosterone with or with the aromatase inhibitor anastrazole as a pellet reduced breast cancer risk. This conclusion should be taken with caution. It is well know that abnormal breast tissue, breast cancer, highly expresses aromatase activity which would increase Testosterone to estradiol production. This would feed any growing tumor. But, this study finds protection. The failure of this study is the measurement of hormone levels.